Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity

BACKGROUND: Castration-resistant prostate cancer (CRPC) is the lethal phenotype of prostate cancer. Lipocalin 2 (LCN2) is aberrantly expressed in many cancers including primary prostate cancer (PCa), but its role in CRPC has not been reported. RESULTS: LCN2 expression was upregulated in human primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Guanxiong, Wang, Jianqing, Feng, Chenchen, Jiang, Haowen, Xu, Jianfeng, Ding, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325444/
https://www.ncbi.nlm.nih.gov/pubmed/27602760
http://dx.doi.org/10.18632/oncotarget.11790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325444/
https://www.ncbi.nlm.nih.gov/pubmed/27602760
http://dx.doi.org/10.18632/oncotarget.11790

Ejemplares similares